Ronald Harold Wilfred Cooper - Jan 19, 2023 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
President and CEO, Director
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Jan 19, 2023
Transactions value $
$0
Form type
4
Date filed
1/25/2023, 07:11 PM
Previous filing
Jan 9, 2023
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Award $0 +195K +339.46% $0.00 252K Jan 19, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 19, 2024, with the remainder vesting in equal installments every three months thereafter beginning on April 19, 2024 and ending on January 19, 2027.
F2 Represents 33,094 shares of common stock and 219,350 restricted stock units.